Compartmentalized HIV-1 replication within the central nervous system (CNS) likely
provides a foundation for neurocognitive impairment and a potentially important tissue …

Background Human immunodeficiency virus type 1 (HIV-1) populations are detected in
cerebrospinal fluid (CSF) of some people on suppressive antiretroviral therapy (ART) …

Human immunodeficiency virus type 1 (HIV-1) invades the central nervous system (CNS)
during primary infection and persists in this compartment by unknown mechanisms over the …

Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system (CNS)
can lead to the development of HIV-1-associated dementia (HAD). We examined the …

Even when antiretroviral therapy (ART) is started early after infection, HIV DNA might persist
in the central nervous system (CNS), possibly contributing to inflammation, brain damage …

To design effective eradication strategies, it may be necessary to target HIV reservoirs in
anatomic compartments other than blood. This study examined HIV RNA rebound following …

Human immunodeficiency virus type 1 (HIV-1) infection occurs throughout the body and can
have dramatic physical effects, such as neurocognitive impairment in the central nervous …

Human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) is a severe
neurological disease that affects a subset of HIV-1-infected individuals. Increased …

HIV cerebrospinal fluid (CSF) escape, where HIV is suppressed in blood but detectable in
CSF, occurs when HIV persists in the CNS despite antiretroviral therapy (ART). To determine …

Human immunodeficiency virus type 1 (HIV-1) invades the central nervous system (CNS)
shortly after systemic infection and can result in the subsequent development of HIV-1 …